Search research articles
Contact Us
Filters
Showing results (441-450 of 606) with videos related to
Page
of 61
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 18, 2019
Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
Samuel T Wilkinson, Cristan Farmer, Elizabeth D Ballard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 18, 2012
Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder
Márcio Gerhardt Soeiro-de-Souza, Giacomo Salvadore, Ricardo Alberto Moreno, et al.
Acta Psychiatrica Scandinavica
|
July 18, 2020
The effects of ketamine on typical and atypical depressive symptoms
L T Park, D A Luckenbaugh, S J Pennybaker, et al.
Journal of Psychiatric Research
|
August 1, 2015
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant
Elizabeth D Ballard, David A Luckenbaugh, Erica M Richards, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 13, 2015
The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition
Panos Zanos, Sean C Piantadosi, Hui-Qiu Wu, et al.
The International Journal of Neuropsychopharmacology
|
June 9, 2012
Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder
Wallace C Duncan, Simone Sarasso, Fabio Ferrarelli, et al.
American Journal of Medical Genetics. Part A
|
June 7, 2016
SMARCE1, a rare cause of Coffin-Siris Syndrome: Clinical description of three additional cases
Yuri A Zarate, Elizabeth Bhoj, Julie Kaylor, et al.
The Journal of Clinical Psychiatry
|
August 7, 2008
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania
Rodrigo Machado-Vieira, Jair C Soares, Diogo R Lara, et al.
Pediatric Research
|
November 7, 2023
Metabolic and fecal microbial changes in adult fetal growth restricted mice
Stephanie P Gilley, Miguel A Zarate, Lijun Zheng, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 31, 2014
Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis
André R Brunoni, Rodrigo Machado-Vieira, Carlos A Zarate, et al.
Page
of 61
Search research articles
Search
Showing results (441-450 of 606) with videos related to
Sort By:
Page
of 61
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 18, 2019
Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
Samuel T Wilkinson, Cristan Farmer, Elizabeth D Ballard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 18, 2012
Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder
Márcio Gerhardt Soeiro-de-Souza, Giacomo Salvadore, Ricardo Alberto Moreno, et al.
Acta Psychiatrica Scandinavica
|
July 18, 2020
The effects of ketamine on typical and atypical depressive symptoms
L T Park, D A Luckenbaugh, S J Pennybaker, et al.
Journal of Psychiatric Research
|
August 1, 2015
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant
Elizabeth D Ballard, David A Luckenbaugh, Erica M Richards, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 13, 2015
The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition
Panos Zanos, Sean C Piantadosi, Hui-Qiu Wu, et al.
The International Journal of Neuropsychopharmacology
|
June 9, 2012
Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder
Wallace C Duncan, Simone Sarasso, Fabio Ferrarelli, et al.
American Journal of Medical Genetics. Part A
|
June 7, 2016
SMARCE1, a rare cause of Coffin-Siris Syndrome: Clinical description of three additional cases
Yuri A Zarate, Elizabeth Bhoj, Julie Kaylor, et al.
The Journal of Clinical Psychiatry
|
August 7, 2008
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania
Rodrigo Machado-Vieira, Jair C Soares, Diogo R Lara, et al.
Pediatric Research
|
November 7, 2023
Metabolic and fecal microbial changes in adult fetal growth restricted mice
Stephanie P Gilley, Miguel A Zarate, Lijun Zheng, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 31, 2014
Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis
André R Brunoni, Rodrigo Machado-Vieira, Carlos A Zarate, et al.
Page
of 61